This announcement is a separate document:
复星医药2022年第一季度报告
Fosun Pharmaceutical's report for the first quarter of 2022
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.